Article

Treatment guidelines for substance use disorders and serious mental illnesses: do they address co-occurring disorders?

University of Michigan, School of Social Work, Ann Arbor, MI, USA.
Substance Use &amp Misuse (Impact Factor: 1.23). 06/2010; 45(7-8):1262-78. DOI: 10.3109/10826080903442836
Source: PubMed

ABSTRACT Practice guidelines are important tools for improving the delivery of evidence-based practices and reducing inappropriate variation in current treatment approaches. This study examined the degree to which guidelines targeted to the treatment of substance use disorders or serious mental illness address treatment of co-occurring disorders. Guidelines archived by the National Guideline Clearinghouse (NGC) were retrieved in December 2007 and content analyzed. Nineteen pertinent guidelines were identified, and 11 included recommendations regarding the assessment and/or treatment of co-occurring disorders. None of the guidelines making recommendations for treatment of co-occurring disorders included outcomes that clearly targeted both substance use and mental health disorders. Limitations and implications of this study are noted.

0 Bookmarks
 · 
150 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: AimsTo measure the effectiveness of antidepressants for adolescents and young adults with co-occurring depression and substance use disorder.Design, setting, participantsMeta-analysis of randomized controlled clinical trials. A comprehensive literature search of PubMed, Cochrane, Embase, Web of Science and PsychINFO was conducted (from 1970 to 2013). Prospective, parallel groups, double-blind, controlled trials with random assignment to an antidepressant or placebo on young patients (age ≤25 years) who met diagnostic criteria of both substance use and unipolar depressive disorder were included. Five trials were selected for this analysis and included 290 patients.MeasurementsOur efficacy outcome measures were depression outcomes (dichotomous and continuous measures) and substance-use outcomes (change of frequency or quantity of substance-use). Secondary analysis was conducted to access the tolerability of antidepressants treatment.FindingsFor dichotomous depression outcome, antidepressants group was significantly more effective than placebo group (RR=1.21; 95% CI 1.01 to 1.45) with low heterogeneity (I2=0%). Although no statistically significant effects for continuous depression outcome (SMD=-0.13; 95% CI, -0.55 to 0.30) were found with moderate heterogeneity (I2=63%), subgroup analysis showed medicine group with sample size of more than 50 showed a statistically significant efficacy compared with the placebo group (SMD -0.53, 95% CI -0.82 to -0.25). Moreover, there was no significant difference for substance-use outcomes and tolerability outcomes between medication group and placebo group.Conclusions Antidepressant medication has a small overall effect in reducing depression in young patients with combined depressive and substance-use disorders but does not appear to improve substance use outcomes.
    Addiction 08/2014; 110(1). · 4.60 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nonmedical prescription opioid use (NMPOU) has become a substantial public health concern in North America. Existing epidemiological data suggest an association between NMPOU and mental health or pain symptoms in different populations, although these correlations are not systematically assessed. To address this gap, a systematic search, review, and meta-analysis were completed separately for both mental health problem symptoms and pain in general population samples reporting NMPOU. Overall, 9 unique epidemiological studies were identified and included in the review. The pooled prevalence of any mental health symptoms in general population samples reporting NMPOU was 32% (95% confidence interval [CI]: 24-40). Specifically, the pooled prevalence of depression was 17% (95% CI: 14-19) and the prevalence of anxiety in general population samples of NMPOU was 16% (95% CI: 1-30) The pooled prevalence of pain in the population of interest was found to be 48% (95% CI: 37-59). This systematic review found evidence for disproportionately high prevalence levels of mental health problems and pain among general population samples reporting NMPOU. While the data reviewed cannot interpret dynamics of potential causality, these findings have implications for interventions for NMPOU, as well as medical practice involving prescription opioids. PERSPECTIVE: This systematic review and meta-analysis found evidence for disproportionately elevated rates of select mental health and pain problems in epidemiological studies based on general population samples reporting NMPOU. While causality cannot be established, these comorbidities may influence NMPOU behavior and hence ought to be considered in preventive and treatment interventions.
    The journal of pain: official journal of the American Pain Society 10/2012; · 4.22 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite the significant attention that drugs and alcohol receive on college campuses, few resources and supports are available to students who are recovering from an addiction. Student affairs professionals are uniquely positioned to support these students with a variety of strategies. This article summarizes what is currently known about college students in recovery and ways that student affairs professionals can help build an infrastructure of formal and informal supports for this underserved and at-risk student population.
    Journal of student affairs research and practice. 01/2011; 48(1):47-64.

Full-text (2 Sources)

Download
49 Downloads
Available from
May 17, 2014